연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1615 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Vogel, Arndt | Vogel, A | 1 | Toronto Gen Hosp, Toronto, ON, Canada | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Chan, Stephen L. | Chan, SL | 2 | Chines Univ Hongkong, Hong Kong, Peoples R China | F-9149-2011 | Chan, Stephen | ||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Furuse, Junji | Furuse, J | 3 | Kyorin Univ, Sch Med, Mitaka, Tokyo, Japan | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Tak, Won Young | Tak, WY | 4 | Kyungpook Natl Univ, Sch Med, Daegu, South Korea | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Masi, Gianluca | Masi, G | 5 | Univ Pisa, Pisa, Italy | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Varela, Maria | Varela, M | 6 | Cent Univ Hosp Asturias, Oviedo, Spain | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Kim, Jee Hyun | Kim, JH | 7 | Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Tanasanvimon, Suebpong | Tanasanvimon, S | 8 | Chulalongkorn Univ, Fac Med, Bangkok, Thailand | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Reig, Maria | Reig, M | 9 | Univ Barcelona, Barcelona, Spain | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Dayyani, Farshid | Dayyani, F | 10 | Univ Calif Irvine, Irvine, CA USA | CAF-8867-2022 | Dayyani, Farshid | ||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Makowsky, Mallory | Makowsky, M | 11 | AstraZeneca, Gaithersburg, MD USA | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Marcovitz, Michelle | Marcovitz, M | 12 | AstraZeneca, Gaithersburg, MD USA | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Negro, Alejandra | Negro, A | 13 | AstraZeneca, Gaithersburg, MD USA | ||||||
| Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study | Abou-Alfa, Ghassan | Abou-Alfa, G | 14 | Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA | ||||||
| Outcomes in patients with out-of-hospital cardiac arrest according to prehospital advanced airway management timing: a retrospective observational study | Lee, Sang-Hun | Lee, SH | 1 | 0000-0003-4303-7375 | Lee, Sang-Hun | ryoo@knu.ac.kr; |
페이지 이동: